Aug 4, 2026 04:05PM
May 5, 2026 04:01PM
Apr 2, 2026 12:00PM
Apr 2, 2026 10:46AM
Apr 2, 2026 08:31AM
Apr 2, 2026 08:30AM
Feb 23, 2026 08:30AM FDA accepts Ultragenyx gene therapy application with priority review
Feb 23, 2026 08:30AM
Feb 12, 2026 04:01PM
Feb 3, 2026 06:44AM
Jan 30, 2026 08:31AM
Jan 30, 2026 08:30AM
Jan 12, 2026 07:31AM
Jan 12, 2026 07:30AM Ultragenyx Provides Financial and Business Updates at J.P. Morgan Annual Healthcare Conference
Jun 23, 2025 10:33AM
May 6, 2025 04:01PM
Feb 19, 2025 07:13AM
Feb 18, 2025 08:07AM
Feb 18, 2025 08:00AM
Feb 18, 2025 06:52AM
Feb 14, 2025 06:57AM Goldman Sachs Reiterates Buy Rating on Ultragenyx Pharma (RARE)
Feb 13, 2025 04:01PM
Feb 5, 2025 08:00AM
Feb 5, 2025 08:00AM
Jan 13, 2025 05:22AM
Jan 12, 2025 11:00AM
May 15, 2023 09:10AM
May 15, 2023 09:08AM Weekly biotech pulse: X4 Pharma data on deck, AbbVie set for FDA review
Jul 1, 2020 08:11AM
May 6, 2020 04:01PM
May 6, 2020 04:01PM
Feb 27, 2020 08:06AM
Feb 27, 2020 08:00AM
Feb 27, 2020 08:00AM
Feb 13, 2020 04:01PM Ultragenyx Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update
Feb 13, 2020 04:01PM
Jan 13, 2020 08:20AM
Jan 13, 2020 08:10AM
Jan 13, 2020 08:10AM
Nov 5, 2019 04:01PM
Nov 5, 2019 04:01PM
Oct 14, 2019 08:32AM Ultragenyx Pharma (RARE) Announces FDA Acceptance of UX007 NDA
Oct 14, 2019 08:30AM
Oct 14, 2019 08:30AM
Feb 23, 2018 08:07AM
Feb 23, 2018 08:00AM
Feb 23, 2018 08:00AM
Feb 23, 2018 08:00AM
Feb 20, 2018 04:05PM Ultragenyx Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Update
Feb 20, 2018 04:05PM

15,682 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All